Tirzepatide
US$ 22.92
what is the new glp 1 drug GLP-1 Guidelines for Type 2 Diabetes in 2025 Considering GLP-1 drugs for weight
Description
& Grigson, P
however, trials developed mainly to evaluate the long-term impact of tirzepatide on cardiovascular events, including stroke, are currently in progress [42]
doi: 10.1111/nmo.13738
P = 0.14) (13)
But they added shadows to the spotlight
The body of evidence across multiple studies in various countries is conclusive that treatment with GLP-1 medications for type 2 diabetes and/or overweight/obesity is strongly associated with an elevated risk of developing NAION
